Antihistamines for increased tolerance to extreme heat

Antihistamines for increased tolerance to extreme heat

Histamine receptor antagonists are administered to delay the onset of or prevent heat stroke in mammals. H2 receptor antagonists including cimetidine, famotidine, nizatidine, and ranitidine are administered to the mammals prior to the exposure of the mammal to stress conditions, such as temperature,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: SMITH-SONNEBORN JOAN
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SMITH-SONNEBORN JOAN
description Histamine receptor antagonists are administered to delay the onset of or prevent heat stroke in mammals. H2 receptor antagonists including cimetidine, famotidine, nizatidine, and ranitidine are administered to the mammals prior to the exposure of the mammal to stress conditions, such as temperature, environmental, drug, exercise, or combinations thereof. The explosive temperature rise and precipitous mean arterial pressure crash seen in untreated subjects were delayed 2.6 fold (p
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2006052430A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2006052430A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2006052430A13</originalsourceid><addsrcrecordid>eNrjZDBzzCvJzMgsLknMzcxLLVZIyy9SyMxLLkpNLE5NUSjJz0ktSsxLTgWyFFIrSopSc1MVMlITS3gYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBgZmBqZGJsYGjoTFxqgB6ES6v</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Antihistamines for increased tolerance to extreme heat</title><source>esp@cenet</source><creator>SMITH-SONNEBORN JOAN</creator><creatorcontrib>SMITH-SONNEBORN JOAN</creatorcontrib><description>Histamine receptor antagonists are administered to delay the onset of or prevent heat stroke in mammals. H2 receptor antagonists including cimetidine, famotidine, nizatidine, and ranitidine are administered to the mammals prior to the exposure of the mammal to stress conditions, such as temperature, environmental, drug, exercise, or combinations thereof. The explosive temperature rise and precipitous mean arterial pressure crash seen in untreated subjects were delayed 2.6 fold (p&lt;0.05) in H2 receptor antagonist-treated animals. The results teach that these antihistamines and acid reducers can increase tolerance to heat stress and may potentially increase survival to heat stress induced by environmental, drug related, or exercise and heat induced stress in athletes, military, and workers required to work in extreme temperature environments.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060309&amp;DB=EPODOC&amp;CC=US&amp;NR=2006052430A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060309&amp;DB=EPODOC&amp;CC=US&amp;NR=2006052430A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SMITH-SONNEBORN JOAN</creatorcontrib><title>Antihistamines for increased tolerance to extreme heat</title><description>Histamine receptor antagonists are administered to delay the onset of or prevent heat stroke in mammals. H2 receptor antagonists including cimetidine, famotidine, nizatidine, and ranitidine are administered to the mammals prior to the exposure of the mammal to stress conditions, such as temperature, environmental, drug, exercise, or combinations thereof. The explosive temperature rise and precipitous mean arterial pressure crash seen in untreated subjects were delayed 2.6 fold (p&lt;0.05) in H2 receptor antagonist-treated animals. The results teach that these antihistamines and acid reducers can increase tolerance to heat stress and may potentially increase survival to heat stress induced by environmental, drug related, or exercise and heat induced stress in athletes, military, and workers required to work in extreme temperature environments.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBzzCvJzMgsLknMzcxLLVZIyy9SyMxLLkpNLE5NUSjJz0ktSsxLTgWyFFIrSopSc1MVMlITS3gYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBgZmBqZGJsYGjoTFxqgB6ES6v</recordid><startdate>20060309</startdate><enddate>20060309</enddate><creator>SMITH-SONNEBORN JOAN</creator><scope>EVB</scope></search><sort><creationdate>20060309</creationdate><title>Antihistamines for increased tolerance to extreme heat</title><author>SMITH-SONNEBORN JOAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2006052430A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SMITH-SONNEBORN JOAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SMITH-SONNEBORN JOAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Antihistamines for increased tolerance to extreme heat</title><date>2006-03-09</date><risdate>2006</risdate><abstract>Histamine receptor antagonists are administered to delay the onset of or prevent heat stroke in mammals. H2 receptor antagonists including cimetidine, famotidine, nizatidine, and ranitidine are administered to the mammals prior to the exposure of the mammal to stress conditions, such as temperature, environmental, drug, exercise, or combinations thereof. The explosive temperature rise and precipitous mean arterial pressure crash seen in untreated subjects were delayed 2.6 fold (p&lt;0.05) in H2 receptor antagonist-treated animals. The results teach that these antihistamines and acid reducers can increase tolerance to heat stress and may potentially increase survival to heat stress induced by environmental, drug related, or exercise and heat induced stress in athletes, military, and workers required to work in extreme temperature environments.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2006052430A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Antihistamines for increased tolerance to extreme heat
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A05%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SMITH-SONNEBORN%20JOAN&rft.date=2006-03-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2006052430A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true